- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
|
|
328 |
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
intervention to promote complete clearance of |
Clinical Manifestations |
|
all infection. Open or percutaneous drainage of |
|
|
abscesses, nephrectomy, adrenalectomy, tran- |
The clinical manifestations of genitourinary TB |
|
surethral resection of the prostate (TURP), |
are a vast and vague collection of symptoms |
|
orchiectomy and biopsies for tissue diagnosis |
that depend on the organ of involvement. TB |
|
are a few of the surgical interventions that might |
can involve nearly all urologic organs as they |
|
adjunct pharmacotherapy. In addition, patients |
course from the mid-abdomen to the pelvis and |
|
with disseminated infections are often immu- |
perineum (Table 24.3). Though it is often |
|
nocompromised and critically ill with a multi- |
asymptomatic,it can present with constitutional |
|
tude of comorbid conditions, this can further |
symptoms (37%), hematuria (51%), irritative |
|
complicate management.5,10 |
voiding symptoms (76%), and recurrent urinary |
|
|
|
tract infections (22%). Pulmonary manifesta- |
Tuberculosis |
tions may be absent in as many as 20–30% of |
|
patients.33 |
||
|
|
Genitourinary TB can spread hematogenously |
The incidence of Tuberculosis (TB) has been on |
to the adrenal glands with abscess and necrosis |
|
the rise since the introduction of HIV in the |
of the adrenals results in the clinical manifesta- |
|
1980s and persistence of other immunocompro- |
tions of Addison’s disease. Corticotrophin stim- |
|
mised conditions, combined with increased |
ulation testing will confirm the diagnosis with a |
|
immigration and the upsurge of drug resistant |
low response. In addition, bilateral adrenal cal- |
|
strains of TB.30 |
cifications may be present by radiographic |
|
Tuberculosis typically manifests as pulmo- |
analysis.30 |
|
nary conditions, but can present in a multi- |
Renal tuberculosis has also been shown to |
|
tude of ways at a variety of sites, giving it the |
result from direct metastatic hematologic seed- |
|
title “The Great Mimic.” Genitourinary TB |
ing of M. tuberculosis to the glomeruli.An acute, |
|
makes up nearly 30% of all the extrapulmo- |
then chronic inflammatory reaction occurs |
|
nary sites of manifestation.31 The great variety |
resulting in granuloma formation and caseaous |
|
of clinical symptoms, combined with the prev- |
necrosis. This inflammation will spread to the |
|
alence of immunocompromised states requires |
renal medulla and papilla with resultant necro- |
|
a thorough knowledge of the possible presen- |
sis. Papillary sloughing can result in intermit- |
|
tations of TB, as well as the presence of a high |
tent renal colic. As extension continues in the |
|
degree of suspicion, and a low threshold to |
renal pelvis, ulceration and calcification with |
|
culture. |
stone formation occur. Calyceal infundibular |
|
Tuberculosis is caused by the aerobic organ- |
stenosis can occur in multiple calyces with resul- |
|
ism Mycobacterium tuberculosis. This slow |
tant obstruction.34 Renal and calyceal abscess |
|
growing organism can exist within the host |
can develop (Fig. 24.2).35 Overall, renal function |
|
phagocyte, lying indolent for many years before |
can be compromised by a combination of |
|
reactivating during a time of host immunocom- |
destruction of renal parenchyma and obstruc- |
|
promise. TB is spread by human droplet expo- |
tive uropathy, resulting in elevated creatinine |
|
sure and Primary TB may present simply as a |
and renal failure in over 40% of patients.30 |
|
self-limited pneumonia-like illness. As the |
Classic CT finding reveal renal punctuate or |
|
inflammatory process subsides and healing |
curvilinear calcifications, with concurrent |
|
begins, fibrosis and calcification may result in |
deformation and blunting of calyces.36 |
|
scar formation or strictures.10 |
Manifestations of TB in the ureters include |
|
Populations at increased risk of manifesting |
inflammation and fibrosis with resultant stric- |
|
genitourinary TB include patients with any con- |
ture disease. Continuous or segmental strictures |
|
dition that creates an immunosuppressed state. |
may be seen anywhere along the course of the |
|
This includes patients with chronic renal failure, |
ureter. Chronic inflammation at the ureteral ori- |
|
diabetics, HIV+ patients, particularly those with |
fices can result in a “golf hole” appearance, and |
|
low CD4 counts, organ transplantation recipi- |
resultant ureterocoele.10 |
|
ents receiving immunosuppressive therapies |
Bladder involvement is typically a sequela of |
|
and IV drug abusers.32 Recent immigrants and |
renal tuberculosis. It can be asymptomatic, but |
|
health care workers are also at risk. |
more commonly presents with irritative voiding |
329
nonBactErial infEctions of tHE gEnitoUrinary tract
Table 24.3. Manifestations and treatment of genitourinary tB |
|
|
|
|||
Organ |
Clinical manifestation |
Radiologic findings |
Treatment |
|||
Kidney and |
− |
chronic hematuria/pyuria |
− |
renal calcifications |
− |
chemotherapy |
renal pelvis |
− |
renal failure |
|
|
|
|
|
|
|
|
|
||
|
− |
renal colic |
− |
caliectasia |
− |
abscess drainage |
|
|
|
− |
Early calyceal blunting |
− |
Partial nephrectomy |
|
|
|
− |
late“motheaten” appearance |
− |
calico/pyelo recon- |
|
|
|
− |
calyceal infundibular stenosis |
|
struction, diversion |
|
|
|
|
or excision |
||
|
|
|
|
|
|
|
adrenal |
− |
adrenal insufficiency and |
− |
Bilateral adrenal calcifications |
cortisol replacement and |
|
|
|
no or dampened response |
|
|
|
chemotherapy |
|
|
to corticotrophin |
|
|
|
|
Ureter |
− |
renal colic |
− |
Ureteral narrowing +/− renal |
− |
chemotherapy |
|
− |
chronic sterile pyuria |
|
calcifications or abscess |
− |
removal of obstruction |
|
|
|
||||
|
− |
Ureterocoele |
|
by stenting or Pcn |
||
|
|
|
|
|||
|
− |
chronic hematuria |
|
|
− |
treatment of renal |
|
|
|
|
manifestations |
||
|
− |
Hydronephrosis |
|
|
|
|
|
|
|
|
|
||
|
− |
strictures |
|
|
|
|
|
− |
renal failure |
|
|
|
|
Bladder |
− |
chronic cystitis |
− |
contracted bladder |
− |
chemotherapy |
|
|
|
− |
irregular bladder shape |
− treatment of upper tract |
|
|
|
|
|
abscesses or obstruction |
||
|
|
|
− “thimble bladder” |
|
||
|
− |
lUts |
|
|
||
|
|
|
|
|
||
|
− |
concurrent Escherichia.coli |
|
|
|
|
|
|
Uti’s |
|
|
|
|
|
− |
Pyuria/microhematuria w/ |
|
|
|
|
|
|
acidic urine |
|
|
|
|
|
− |
Erythema/bullous edema |
|
|
|
|
|
− |
Mucosal ulcers/erosions |
|
|
|
|
|
− |
Mucosal fibrosis |
|
|
|
|
Prostate |
− |
Prostatits |
− |
calcifications in prostate |
− |
chemotherapy |
|
− |
nodular, fixed, or firm |
− |
cavitary lesion on Mri |
− |
drainage of absesses |
|
|
|
||||
|
|
prostate |
|
|
|
|
|
− |
Elevate Psa |
|
|
|
|
Urethra |
− |
Ulcerative urethritis |
− |
“cyst-like” lesions in prostatic |
− |
chemotherapy |
|
− |
strictures |
|
urethra |
− |
Endoscopic excision or |
|
|
|
||||
|
|
|
|
urethroplasty |
||
|
− “Beefy red” mucosa |
|
|
|
||
|
|
|
|
|
||
|
− |
“golf hole” prostatic ducts |
|
|
|
|
Penis |
− |
indurated tuberculids |
− |
cavernosal abscess |
− |
chemotherapy |
|
− |
Ulcers |
|
|
− Biopsy to rule out cancer |
|
|
|
|
|
|
(continued)
330
Practical Urology: EssEntial PrinciPlEs and PracticE
Table 24.3. (continued)
Organ |
Clinical manifestation |
Radiologic findings |
Treatment |
scrotum |
− |
granulomatous |
|
|
epididymitis |
|
− |
Painful scrotal mass |
reproductive |
− |
infertility |
organs |
− |
Epididymal or ejaculatory |
|
||
|
|
duct stenosis/ obstruction |
−Enlarged, heterogeneous epididymis
−Epididymal mass with possible cord extension
−calcifications and thickening of epididymis, seminal vesicles, or vas deferens
−long term (2 years)
−chemotherapy
−abscess drainage
−orchiectomy
−chemotherapy
−icsi
−Microsurgical repair/ excision of obstructed ducts
Figure 24.2. renal tuberculosis. ct scan demonstrating right perinephric abscess in 40-year-old female with multiple sclerosis and renal tuberculosis.
symptoms of urgency, frequency, and microhematuria. A low threshold of suspicion should be applied to patients with chronic cystitis, microhematuria,and sterile pyuria with acidic urine.30 TB can coexist with a concurrent Escherichia coli UTI,34 but will be resistant to typical antimicrobials. Cystoscopic evaluation will often reveal inflammation with erythema bullous edema surrounding the ureteral orifice resulting in meatal stenosis and hydroureter or ureterocoele. Mucosal ulcerations may develop,and long-term fibrosis results in a contracted, irregularly shaped bladder often termed a “thimble bladder.”35 Bladder capacities will be severely diminished and may be as low as 100–200cc’s, Biopsy will reveal caseating granulomas that will help clinch the diagnosis.30
Penile tuberculosis, though rare, has been associated with transmission though direct or sexual contact. Patients typically present with tuberculids, or small areas of induration with possible ulceration on the glans of the penis. These lesions are indistinguishable from cancer or syphilis, but histologic analysis may reveal caseating graunlomas.37 Infection of the cavernosa can occur with penile thickening or abscess formation that may result in peyronie’s curvature, loss of erectile function due to fibrosis, and decreased elasticity of the tunica albuginea.38
Chronic granulomatous prostatitis is theorized to be spread by hematogenous route. Patients often present with a nodular fixed prostate on rectal examination and elevated prostate specific antigen (PSA). Both parameters will improve after treatment by antituberculin medications. Clinically indistinguishable from, and can coexist with, cancer of the prostate, it can be diagnosed by prostate biopsy or TURP. Tuberculin prostatitis is usually asymptomatic, and can be found in nearly 15% of prostatic specimens of tuberculosis patients. In addition,“golf hole” dilation of the prostatic ducts can be seen on urethroscopy.33
Scrotal transmission of TB is thought to spread by hematologic, lymphatic, retrourethral, or by direct contact or extension.39 Clinical manifestations typically include a painful scrotal mass, with involvement of the epididymis. Epididymal infections occur by hematogenous transmission, beginning at the richest source of epididymal blood supply, the globus minor. Epididymal infection can spread by direct extension to the testicles. Biopsies reveal acid-fast bacteria and caseating granulomas of the tunica vaginalis and testes.30,33
331
nonBactErial infEctions of tHE gEnitoUrinary tract
Genitourinary tuberculosis can present as |
Ultrasound can be helpful when elucidating |
||
male infertility with obstructive azoospermia |
abnormalities in the prostate, seminal vesicles, |
||
from fibrosis and scarring of the epididymal |
orscrotum.Findingsofcalcifications,hypoechoic |
||
and ejaculatory ducts, or leukocytospermia. |
irregular testicular masses, irregular epididy- |
||
Physical examination will reveal hardened pros- |
mal-testicular margins, hyperechogenicity of |
||
tatic nodules, epididymal dilation, and thick- |
epididymis, and atrophy or swelling of the semi- |
||
ened seminal vesicles. |
|
nal vesicles are suggestive of TB.42 |
|
The intravesical administration of the inac- |
Recently, molecular techniques have been |
||
tive bacilli Calmette-Guerin tuberculosis strain |
making advances in rapid, specific diagnosis of |
||
for superficial bladder cancer is most commonly |
tuberculosis. Polymerase chain reaction has a |
||
associated with local, mild side effects. Systemic |
demonstrated 94% sensitivity in known TB pos- |
||
sepsis is a rare complication of this common |
itive patients.32 |
||
treatment, characterized by fevers, rigors, |
|
||
hypotension, mental status changes, coagulopa- |
|
||
thy,and acute lung injury.This serious side effect |
|
||
has significant morbidity and mortality and |
Treatment |
||
requires aggressive antituberculin therapy.40 |
|
||
|
|
|
Antituberculosis chemotherapy is the mainstay |
|
|
|
of all genitourinary tuberculosis (Table 24.2). |
Diagnosis |
|
|
Recently, an increase in resistant strains of TB, as |
|
|
|
well as the long duration of chemotherapeutic |
While TB’s manifestations are often vague and |
regimens necessitate aggressive treatment and |
||
nonspecific, the clinical genitourinary clinical |
active follow-up with patient reinforcement and |
||
manifestations will be resistant to standard meth- |
counseling and often directly observed adminis- |
||
ods of treatment and antimicrobial therapies. |
tration.Initially,the patient is treated for 2 months |
||
Diagnosis often starts with a cutaneous puri- |
with a four drug combination of isoniazid,pyrazi- |
||
fied protein derivative (PPD) skin test, with the |
namide, rifampin, and ethambutol. At the confir- |
||
injection of purified protein derivative. Results |
mation of culture sensitive lack of resistance, |
||
must be interpreted cautiously, as a false-positive |
ethambutol may be discontinued. Liver enzymes |
||
is seen in patients previously vaccinated against |
must be closely monitored during therapy. |
||
TB, and false-negatives can be seen with severely |
Patients must be advised to refrain from unpro- |
||
blunted immune responses.30 |
tected sexual activity for 4–6 weeks during initial |
||
The diagnosis of TB can often be made from |
treatment, due to the risks of sexual transmission |
||
urine analysis and culture. Initially, pyuria with |
of tuberculosis.Completion therapy must be con- |
||
acidic urine and the absence of typical patho- |
tinued for a total of 6–9 months.33 |
||
gens with urine culture should prompt special |
In addition to chemotherapeutic regimens, |
||
cultures for tuberculosis. These take as long as 8 |
aggressive drainage of all abscesses, debride- |
||
weeks in a specific culture medium.32 In addi- |
ment of infected tissue, and diversion in the |
||
tion, drained abscess or tissue cultures may |
presence of urinary obstruction, many of the |
||
reveal tuberculosis. |
|
long-term sequelae of genitourinary TB require |
|
Histologic |
specimens |
may retrospectively |
definitive surgical management. Ureteral stric- |
cinch the diagnosis with the presence of acid- |
ture might require reimplantation, boari flap, |
||
fast bacilli as well as caseating granulomas or |
or ileal interposition to relieve obstruction. |
||
Langhans giant cells.30 |
|
Bladder contractures can be augmented. Urethral |
|
Radiographic findings, while generally non- |
strictures may be treated by endoscopic incision |
||
specific, can suggest the diagnosis of genitouri- |
or urethroplasty. Seminal vesicle tuberculosis |
||
nary TB. CT remains the most accurate method |
may require abscess drainage, while scrotal |
||
of delineating gross abnormalities commonly |
tuberculosis can necessitate epididymectomy or |
||
seen with tuberculosis.36 Classically, CT will |
orchiectomy.33 Infertility due to obstruction |
||
reveal the presence of renal or caliceal abscesses, |
might be relieved by microsurgical vasovasos- |
||
blunted calyces, infundibular stenosis, renal |
tomy or vasoepididymostomy.In advanced cases, |
||
curvilinear or punctate calcifications, ureteral |
testicular biopsy with sperm extraction and |
||
stricture, and calcifications or abscesses of the |
intracytoplasmic sperm injection (ICSI) can |
||
vas deferens, |
prostate, |
or seminal vesicles.41 |
restore fertile potential.43 |